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 Background: Concurrent with the recent rise of the incidence in obesity, nonalco-
holic fatty liver disease is increasingly prevalent in childhood. The aim of this study 
was to identify non-invasive biomarkers for liver steatosis in obese children and 
adolescents. 
 Methods: We used a cross-sectional study to examine risk factors for liver steatosis 
in obese children and adolescents. Sixty-nine obese subjects aged 6−17 years were 
recruited. The diagnosis of liver steatosis was made by liver ultrasonography. 
Anthropometric, serum biochemical variables, and oral glucose tolerance tests 
were measured. 
 Results: Thirty-eight (55.1%) subjects had liver steatosis. Elevated alanine amino-
transferase levels ( > 30 IU/L in boys and  > 19 IU/L in girls) were found in 27 (71.1%) of 
the 38 subjects with liver steatosis. In multivariate logistic regression analysis, liver 
steatosis was associated with waist circumference and the change of plasma glucose 
level before and after oral glucose tolerance testing (C-OGTT). For every 5 cm 
increase in waist circumference, there was an odds ratio of 1.391 for predicting liver 
steatosis (95% confidence interval: 1.009−1.916,  p = 0.044). C-OGTT was the only lab-
oratory variable that independently predicted liver steatosis, with an odds ratio of 
1.198 (95% confidence interval: 1.022−1.404,  p = 0.026) for each 5 mg/dL of increase. 
 Conclusion: In this hospital-based sample of obese children and adolescents, liver 
steatosis was common. Liver steatosis was positively associated waist circumfer-
ence and C-OGTT. These findings have implications for screening liver steatosis in 
obese children and adolescents. 
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 1. Introduction 
 Non-alcoholic fatty liver disease (NAFLD) represents a 
spectrum of conditions that ranges from simple liver 
steatosis to potentially fatal steatohepatitis. 1 Reports 
of pediatric NAFLD in obese children have been in-
creasing 2,3 and include cases of cirrhosis 4−6 and liver 
transplantation. 7 Obesity is clearly associated with 
NAFLD, but only a subset of obese children develop 
the condition. A better understanding of associated 
risk factors is required to prevent pediatric patients 
at risk from developing NAFLD. Previous epidemio-
logic studies in children revealed that the associated 
risk factors are increased body mass index (BMI), 
older age, male gender, Hispanic ethnicity, and Asian 
race, especially in children of Filipino background. 8 
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 Since obesity is the major risk factor for the de-
velopment of NAFLD, the prevalence of the disease 
has risen along with the dramatic increase in pedi-
atric obesity in the past few decades. In Taiwan, 
based on data from the Elementary School Chil-
dren’s Nutrition and Health Survey conducted in 
2001−2002, the prevalence of obesity was esti-
mated to be 12% among 6−12-year-olds. 9 Concur-
rent with the epidemic of childhood obesity, NAFLD 
is emerging as an important clinical condition in 
Taiwan. However, published literature that discusses 
this issue is limited. 
 Obesity and metabolic risk factors related to 
obesity are known to track from childhood into 
adulthood; 10 therefore, the detection of NAFLD in 
childhood may be fundamental to early interven-
tion and development of primary prevention strat-
egies for NAFLD in at-risk populations. The aim of 
the present study was to identify non-invasive bi-
omarkers for liver steatosis in obese children and 
adolescents, such as sex, BMI, waist circumference, 
insulin resistance, plasma glucose level (fasting and 
2 hours after glucose challenge), blood pressure, 
lipid profile, uric acid, and high sensitivity C-reactive 
protein (hsCRP). Histological examination of liver 
biopsy specimens is required for the definitive di-
agnosis of nonalcoholic steatohepatitis; 11 however, 
this procedure is invasive. Therefore, in this study, 
we used liver ultrasound as the diagnostic modality. 
We scored the ultrasonographic findings of the liver 
and diagnosed steatosis. 
 2. Materials and Methods 
 2.1. Study population 
 From February 2006 to April 2008, 69 obese children 
aged 6−17 years were enrolled from the pediatric 
clinic at Far Eastern Memorial Hospital. Obesity 
was defined as BMI  > 95th percentile with age- and 
gender-adjustment, according to the standard of 
the De partment of Health in Taiwan. 9 Diagnosis re-
quires exclusion of other causes of chronic hepati-
tis including hepatitis B, hepatitis C, autoimmune 
hepatitis, and Wilson’s disease. Alcohol intake is 
excluded on the basis of reported history. All partici-
pants’ parents gave informed consent; the ethics 
committee at the Hospital approved this study. 
 2.2. Demographic data 
 At the time of clinic visit, data on the child’s age, 
gender, BMI, waist circumference, family history 
(including diabetes), obesity, hyperlipidemia, hepa-
tobiliary disease, and hypertension were obtained. 
BMI was calculated as weight (kg) divided by height 
(m) squared. Waist circumference was measured at 
the navel level at the end of a normal expiration. 
 2.3. Laboratory investigations 
 A venous blood sample was collected in the morning 
after fasting for 8 hours when the children were 
free of acute illness. Biochemical measurements 
were performed on fresh serum by Roche reagents 
(Roche Diagnostics, Indianapolis, IN, USA) as follows: 
alanine aminotransferase (ALT), aspartate amino-
transferase (AST),  γ -glutamyl-transpeptidase (GGT), 
fasting glucose, triglyceride, total cholesterol, high-
density lipoprotein (HDL) cholesterol, and uric acid. 
ALT was measured by Kinetic UV test on a Hitachi 
7600 Analyzer (Hitachi, Tokyo, Japan). In this study, 
elevated ALT levels were defined using updated and 
gender-related cutoff values (ALT  > 0.50 μkat/L for 
boys and  > 0.32 μkat/L for girls). 12 
 The remaining serum was frozen at −80ºC. Assays 
for fasting insulin and hsCRP were performed using 
stored sera. Insulin levels were measured using che-
miluminescence immunoassay (DPC, Los Angeles, 
CA, USA). Levels of hsCRP were measured using an 
immunonephelometry assay (Dade Behring Inc., 
Newark, NJ, USA). 
 Insulin resistance was measured by homeostasis 
model assessment of insulin resistance (HOMA-IR), 
which was defined as: HOMA-IR = (fasting insulin 
[pmol/L])  × (fasting glucose [mmol/L]/156.3). 13 This 
has been proved as a valid index in prepubertal and 
pubertal obese children. 14 An oral glucose-tolerance 
test was performed with the administration of 1.75 g 
of glucose per kilogram of body weight (maximal 
dose, 75 g). Impaired oral glucose tolerance was 
defined as a glucose level greater than 7.77 mmol/
L but less than 11.0 mmol/L at two hours (2-hour 
plasma glucose level [2-hr PG]). 15 C-OGTT was de-
fined as the change in plasma glucose level before 
and after oral glucose tolerance testing. 
 2.4. Liver ultrasonography 
 All participants underwent an ultrasonographic 
study of the liver performed by one operator (the 
first author). The hand-carried machine used 
(EnVisor C; Royal Philips Electronics Inc., Amsterdam, 
Netherlands) was equipped with an 8−3.5 MHz 
curved linear array probe (C5040; Royal Philips 
Electronics Inc.). 
 Liver steatosis was defined as the presence of an 
ultrasonographic pattern consistent with the fol-
lowing criteria: (1) liver-kidney echo discrepancy; 
(2) attenuated echo penetration and visibility of 
diaphragm; and (3) obscure hepatic vessel struc-
tures. Liver steatosis was scored by the above ul-
trasonographic features as described by Chan et al 
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(Table 1). 16 To improve the positive predictive value 
of liver ultrasonography, we used a more strict 
threshold; thus, a score of ≥ 4 was defined as liver 
steatosis in this study. 
 2.5. Statistical analysis 
 The statistical software SAS (version 9.1; SAS Institute 
Inc., Cary, NC, USA) was used in data analysis. 
Qualitative variables were expressed as proportions 
and compared using the χ 2 test, continuous varia-
bles were expressed as  mean  ± SD and compared 
using the independent two-sample  t test. 
 In addition to these univariate analyses, multivar-
iate analyses were performed by fitting multiple 
logistic regression models to identify independent 
factors associated with liver steatosis. To ensure the 
quality of the results, the basic model-fitting tech-
niques for (1) variable selection, and (2) goodness-
of-fit (GOF) assessment were used in our regression 
analyses. Specifically, in the stepwise variable se-
lection procedure, all the univariate significant and 
non-significant covariates (except AST, ALT and  γ GT) 
were considered. The significance levels for entry 
and for stay were set to 0.15 or larger. Both the 
GOF measures, such as percentage of concordant 
pairs and adjusted generalized  R 2 , and the GOF tests, 
such as deviance GOF test, Hosmer-Lemeshow test, 
and Pearson’s χ 2 GOF test, were examined to assess 
the GOF of the fitted logistic regression model. 
Two-sided  p  < 0.05 was considered as statistically 
significant. 
 3. Results 
 3.1. Subject characteristics 
 A total of 69 obese subjects were recruited. The 
mean age was 11.5 years (range, 6.3−17.6 years); 
53 participants (76.8%) were male; 38 (55.1%) had 
ultrasonographic liver steatosis; and 26 (49.1%) 
boys and 7 (43.8%) girls had elevated ALT levels. 
The mean BMI was 31.1 kg/m 2 , with a range of 
23.2−44.8 kg/m 2 . Seven (10.1%) were hypertriglyc-
eridemic (fasting triglyceride  > 1.70 mmol/L), 12 
(17.4%) had hypercholesterolemia (fasting total cho-
lesterol  > 5.18 mmol/L), 12 (17.4%) had low HDL-
cholesterol (HDL cholesterol  < 1.04 mmol/L), 2 (2.9%) 
had hyperglycemia (fasting glucose  > 6.11 mmol/L), 
9 (13.0%) had hyperinsulinemia (fasting insulin 
 >  138.9 pmol/L), and 26 (37.7%) had insulin resis-
tance (defined by HOMA-IR  > 2 16 ). Eight (13.0%) had 
impaired oral glucose tolerance; of note, two had 
a fasting plasma glucose level  > 6.11 mmol/L and 
2-hr PG  > 11.1 mmol/L, compatible with the crite-
ria for the diagnosis of diabetes. Both also had 
liver steatosis and elevated ALT levels. They were 
transferred to our endocrinology clinic for further 
management. 
 3.2. Factors associated with liver steatosis 
 3.2.1. Univariate analysis 
 The enrolled obese participants were divided into 
two categories according to the liver steatosis, as 
defined by ultrasonographic findings: 31 without 
liver steatosis and 38 with liver steatosis. Table 2 
presents the demographic features, anthropomet-
ric measurements and laboratory data between 
participants with and without liver steatosis. More 
male and older-aged participants were found among 
those with liver steatosis. Participants with liver 
steatosis had a greater waist circumference, higher 
systolic and diastolic blood pressure, as well as 
higher ALT, AST and  GGT levels. There were no sig-
nificant differences between subjects with and 
without liver steatosis for BMI. The 2-hr PG level 
and C-OGTT were significantly higher in those with 
 Table 1  Ultrasonographic scoring for liver steatosis 
 Ultrasound features  Score  Definition 
 Liver echotexture  0  No difference in contrast between liver parenchyma and kidney parenchyma 
  1  Slightly increased 
  2  Between 1 and 3 
  3  Large discrepancy between hepatic and renal echoes 
 Echo penetration  0  Clearly defined liver structures and diaphragm 
  1  Mild attenuation 
  2  Between 1 and 3 
  3  Marked opacity of the lower part of the liver and loss of visibility of diaphragm 
 Clarity of vessel  0  Clearly defined vessel structures 
 structures  1  Slight decreased definition of portal venule walls 
  2  Between 1 and 3 
  3  Markedly obscure vessel structures and unidentifiable vessel walls 
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liver steatosis compared with those without liver 
steatosis. However, there was no difference in terms 
of impaired oral glucose tolerance (the 2-hr PG 
criterion of  > 7.77 mmol/L). 
 To further assess elevated ALT levels in subjects 
with liver steatosis, we analyzed the relationship 
between them. As depicted in Figure 1, there was a 
significant difference between elevated ALT levels 
and liver steatosis ( p  < 0.001). Among subjects with-
out liver steatosis, the percentage of elevated ALT 
was 13.6% in boys and 22.2% in girls. In contrast, 
elevated ALT levels were prevalent among 74.2% 
of boys and 57.1% of girls with liver steatosis. 
 3.2.2. Multivariate analysis 
 We use multivariate logistic regression to identify 
independent factors for liver steatosis. Age was 
put in the final multivariate model to adjust for its 
effect on other independent variables. Similar to 
the results from univariate analysis, waist circum-
ference and C-OGTT were selected as positive fac-
tors in the multivariate model. In contrast to the 
results from univariate analysis, sex and blood pres-
sure were not selected as independent factors of 
liver steatosis in multivariate analysis. For every 5 cm 
increase in waist circumference, there was an odds 
ratio of 1.391 (95% confidence interval: 1.009−


























Figure 1 Percentage elevated alanine aminotransferase 
(ALT) levels by liver steatosis group and sex. The percent-
age of elevated ALT level was significantly higher in sub-
jects with liver steatosis than those without liver steatosis 
(p < 0.001, χ2 test).
Table 2  Basic characteristics of the subjects 
 Variables No liver steatosis* ( n =  31) Liver steatosis present ( n = 38)  p † 
 Age (yr) 10.8 ±  2.4 12.1 ±  2.5 0.040‡ 
 Male (%) 71.0 81.6 0.030‡ 
 BMI (kg/m 2 ) 30.2 ±  4.3 31.9 ±  4.5 0.115 
 Waist circumference (cm) 88.0 ±  14.5 98.4 ±  9.7 0.002 § 
 SBP (mmHg) 115.2 ±  12.5 126.1 ±  13.9 0.002 § 
 DBP (mmHg) 73.3 ±  8.6 78.1 ±  9.5 0.039 ‡ 
 ALT (kat/L) 0.456 ±  0.566 1.05 ±  0.920 0.002 § 
 AST (kat/L) 0.389 ±  0.119 0.630 ±  0.324  <  0.001 § 
 GGT (kat/L) 0.360 ±  0.153 0.722 ±  0.668 0.003 § 
 FPG (mmol/L) 4.90 ±  0.339 5.13 ±  0.793 0.110 
 Impaired fasting glucose (%) 0 5.3 0.195 
 2-hr PG (mmol/L) 5.54 ±  1.00 6.53 ±  1.62 0.003 § 
 Impaired glucose tolerance (%) 9.7 13.2 0.653 
 C-OGTT (mmol/L) 0.65 ±  1.06 1.39 ±  1.23 0.011 ‡ 
 Insulin (pmol/L) 61.1 ±  48.6 75.0 ±  68.1 0.360 
 HOMA-IR 1.89 ±  1.49 2.49 ±  2.31 0.197 
 Total cholesterol  (mmol/L) 4.50 ±  0.88 4.40 ±  0.70 0.584 
 Triglycerides (mmol/L) 1.20 ±  0.69 1.17 ±  0.44  0.839 
 HDL-C (mmol/L) 1.25 ±  0.24 1.30 ±  0.28 0.447 
 Uric acid (mol/L) 393 ±  89 422 ±  101 0.183 
 hsCRP (mg/dL) 0.36 ±  0.34 0.39 ±  0.40 0.713 
 *Unless otherwise indicated, data are expressed as  mean ±  SD ;  † Independent two-sample  t test for continuous variables and χ 2 
test for categorical variables;  ‡ p  <  0.05;  § p  <  0.01. BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; 
ALT = alanine aminotransferase; AST = aspartate aminotransferase;  GGT =  γ -glutamyl-transpeptidase; FPG = fasting plasma glucose; 
2-hr PG = 2-hour plasma glucose level; C-OGTT = change of plasma glucose level before and after oral glucose tolerance testing; 
HOMA-IR = index of insulin resistance calculated according to the HOMA method; HDL-C = high-density lipoprotein cholesterol; 
hsCRP = high sensitivity C-reactive protein.
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the only laboratory variable that independently 
predicted liver steatosis with an odds ratio of 
1.198 (1.022−1.404) for each 5 mg/dL (0.28 mmol/L) 
increase (Table 3). 
 4. Discussion 
 In this hospital-based study, we demonstrated that 
the independent factors of liver steatosis in obese 
children and adolescents are waist circumference 
and C-OGTT. Age, sex and blood pressures are as-
sociated with NAFLD in univariate analyses, but 
not after adjustment for waist circumference and 
C-OGTT. 
 Several NALFD studies 17 in adults have shown vis-
ceral adiposity to be more influential than BMI. In 
a recent pediatric study, Fishbein et al 18 showed a 
positive correlation between hepatic fat content 
and visceral adipose tissue using magnetic reso-
nance imaging. Consistent with previous studies, 
we found waist circumference to be the more influ-
ential factor in liver steatosis than BMI. The ration-
ale for using this factor in predicting liver steatosis 
is that it is a surrogate measure of central obesity 
and a known predictor of early and late metabolic 
complications of childhood obesity. 19,20 In presence 
of central obesity, the increased amount of visceral 
adipose tissue is resistant to insulin and exhibits a 
greater lipolysis. Increased free fatty acid influx to 
the liver leads to fatty liver, which then worsens the 
hepatic insulin resistance, causing more fat accu-
mulation in the liver, leading to a vicious cycle. 21,22 
 Associations between insulin resistance and NAFLD 
have been found by previous studies of obese chil-
dren. 6,23 Insulin resistance is thought to be the key 
factor in NAFLD, leading to excess fatty acid accu-
mulation in the liver. 24 In the present study, among 
the several biomarkers for glucose and insulin metab-
olism, we found C-OGTT to be the only independent 
risk factor, suggesting that C-OGTT was better for 
predicting liver steatosis than fasting plasma glucose, 
insulin, or HOMA-IR. Some studies have demonstrated 
a reduced oral glucose tolerance associated with 
fatty liver and rising ALT in children. 25 If this proves 
to be true, C-OGTT might be useful for screening and 
identifying obese children and adolescents who are 
at high risk for NAFLD. However, questions still re-
main regarding the cut-off point used as the criterion 
to define a risk threshold. Although C-OGTT was an 
independent predictor of liver steatosis, the 2-hr 
PG > 7.77 mmol/L, the currently defined cut-off point 
for impaired glucose tolerance, 15 was too high to 
identify all high-risk subjects for liver steatosis in our 
subjects. Thus, further research is needed to im-
prove our understanding of these issues. 
 Several limitations existed in the present study. 
First, our study was cross-sectional in design; we 
were unable to confirm a cause-and-effect relation-
ship between risk factors and liver steatosis. Second, 
the diagnostic modality used in this study was liver 
ultrasonography, which is limited in its ability to 
stage hepatic fibrosis in NAFLD. 26 Addi tional investi-
gations should address whether waist circumference 
and C-OGTT are associated with different severity 
of NAFLD. Third, to limit the potential bias of false-
positive diagnosis, we selected an ultrasonographic 
score ≥ 4 as the criterion for liver steatosis in this 
study. As a result, individuals with mild liver stea-
tosis might have been misclassified into the no liver 
steatosis group. Nevertheless, such misclassifica-
tion would generally decrease the power to detect 
differences, rather than leading to bias toward a 
significant difference. Therefore, it is unlikely that 
this issue contributed to the positive findings. 
 In conclusion, liver steatosis is associated with 
waist circumference and C-OGTT in obese children 
and adolescents in Taiwan. The rapid-growing epi-
demic of NAFLD in obese children and adolescents 
emphasizes the need to identify subjects at high-
risk before their full-blown presentation. Our find-
ings could potentially be utilized to identify 
pediatric obese population who may benefit from 
screening for NAFLD. 
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Table 3  Odds ratio of having liver steatosis using the multivariate logistic regression analysis with waist circum-
ference and the change of plasma gluclose level before and after oral glucose tolerance testing (C-OGTT) 
as predictors
Variable Coefficient estimate Odds ratio (95% CI) p
Age 0.1382 1.148 (0.880−1.498) 0.309
Waist circumference (per 5 cm increase) 0.3299 1.391 (1.009−1.916) 0.044
C-OGTT (per 5 mg/dL increase) 0.1802 1.198 (1.022−1.404) 0.026
CI = confidence interval.
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